...
首页> 外文期刊>Inhalation toxicology >Changing the dose metric for inhalation toxicity studies: short-term study in rats with engineered aerosolized amorphous silica nanoparticles.
【24h】

Changing the dose metric for inhalation toxicity studies: short-term study in rats with engineered aerosolized amorphous silica nanoparticles.

机译:更改吸入毒性研究的剂量标准:对经过工程化雾化的无定形二氧化硅纳米粒子的大鼠的短期研究。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Inhalation toxicity and exposure assessment studies for nonfibrous particulates have traditionally been conducted using particle mass measurements as the preferred dose metric (i.e., mg or microg/m(3)). However, currently there is a debate regarding the appropriate dose metric for nanoparticle exposure assessment studies in the workplace. The objectives of this study were to characterize aerosol exposures and toxicity in rats of freshly generated amorphous silica (AS) nanoparticles using particle number dose metrics (3.7 x 10(7) or 1.8 x 10(8) particles/cm(3)) for 1- or 3-day exposures. In addition, the role of particle size (d(50) = 37 or 83 nm) on pulmonary toxicity and genotoxicity endpoints was assessed at several postexposure time points. A nanoparticle reactor capable of producing, de novo synthesized, aerosolized amorphous silica nanoparticles for inhalation toxicity studies was developed for this study. SiO(2) aerosol nanoparticle synthesis occurred via thermal decomposition of tetraethylorthosilicate (TEOS). The reactor was designed to produce aerosolized nanoparticles at two different particle size ranges, namely d(50) = approximately 30 nm and d(50) = approximately 80 nm; at particle concentrations ranging from 10(7) to 10(8) particles/cm(3). AS particle aerosol concentrations were consistently generated by the reactor. One- or 3-day aerosol exposures produced no significant pulmonary inflammatory, genotoxic, or adverse lung histopathological effects in rats exposed to very high particle numbers corresponding to a range of mass concentrations (1.8 or 86 mg/m(3)). Although the present study was a short-term effort, the methodology described herein can be utilized for longer-term inhalation toxicity studies in rats such as 28-day or 90-day studies. The expansion of the concept to subchronic studies is practical, due, in part, to the consistency of the nanoparticle generation method.
机译:传统上,使用颗粒质量测量作为首选剂量指标(即mg或microg / m(3))进行非纤维颗粒的吸入毒性和暴露评估研究。然而,目前关于在工作场所进行纳米颗粒暴露评估研究的合适剂量指标存在争议。这项研究的目的是使用颗粒数量剂量指标(3.7 x 10(7)或1.8 x 10(8)颗粒/ cm(3))表征新鲜生成的无定形二氧化硅(AS)纳米颗粒在大鼠中的气溶胶暴露和毒性。 1天或3天的曝光。此外,在暴露后的几个时间点评估了粒径(d(50)= 37或83 nm)对肺毒性和遗传毒性终点的作用。为此研究开发了一种纳米颗粒反应器,该反应器能够生产从头合成的雾化无定形二氧化硅纳米颗粒,用于吸入毒性研究。 SiO(2)气溶胶纳米粒子合成是通过原硅酸四乙酯(TEOS)的热分解而发生的。设计反应器以产生两个不同粒径范围的雾化纳米颗粒,即d(50)=约30 nm和d(50)=约80 nm;颗粒浓度范围从10(7)到10(8)/ cm(3)。反应堆始终产生AS颗粒气溶胶浓度。在暴露于非常高的颗粒数(对应于一定的质量浓度范围(1.8或86 mg / m 3))的大鼠中,暴露1天或3天的气溶胶不会产生明显的肺部炎症,遗传毒性或不利的肺组织病理学影响。尽管本研究是一项短期努力,但本文所述的方法可用于大鼠的长期吸入毒性研究,例如28天或90天研究。部分由于纳米颗粒产生方法的一致性,将该概念扩展到亚慢性研究是可行的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号